Schedule 13G ownership disclosure

ContraVir Pharmaceuticals, Inc.

Security class unavailable

Event date: 2016-08-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,203,579
Percent of class
14.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-140283
Form type
SC 13G
Filer
CERRONE GABRIEL
CIK
CIK 1253803
Filed
Aug 17, 2016
Reporting period
Aug 17, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub